Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
In this large observational study, GLP-1 RAs showed long-term protective effects on cardiovascular health, renal outcomes and adverse events in individuals with obesity and without T2D. Our findings suggest that GLP-1 RAs may offer a comprehensive approach to managing obesity and its related comorbidities, potentially improving overall health and survival in this population.
Authors
- Chung‐Hsing Wang (ORCID: https://orcid.org/0000-0003-0395-6123)
- Shun‐Fa Yang (ORCID: https://orcid.org/0000-0002-0365-7927)
- Pen‐Hua Su (ORCID: https://orcid.org/0000-0001-6627-9364)
- Wen‐Ling Liao (ORCID: https://orcid.org/0000-0003-1223-8844)
- Chieh‐Chen Huang (ORCID: https://orcid.org/0000-0002-3739-6315)
- Jing‐Yang Huang (ORCID: https://orcid.org/0000-0002-0794-9388)
- Yu‐Nan Huang (ORCID: https://orcid.org/0000-0003-1688-1685)
- Yu‐Jung Lin (ORCID: https://orcid.org/0000-0001-5757-1021)
Institutions
- National Chung Hsing University (TW)
- China Medical University (TW)
- Tzu Chi University (TW)
- Tzu Chi Foundation (TW)
- Chung Shan Medical University Hospital (TW)
- China Medical University Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1111/dom.15869
- Citations
- 29
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.37
Funders
- Chung Shan Medical University Hospital